Barclays
June 4, 2026
Americas Small Cap Research Summary
Market ReportEquitiesHealth CareConsumer Discretionary
This Barclays summary covers key rating and price target changes for Americas small-cap stocks including Alpha Tau, ODDITY Tech, and Sprinklr as of June 4, 2026.
Key Takeaways
- 1.Alpha Tau's price target was raised to $17.00 following a Tolmar commercialization deal and US trial plan approval for prostate cancer.
- 2.ODDITY Tech's price target was slashed from $13.00 to $8.00 as it continues to struggle with its largest advertising partner dislocation.
- 3.Inventiva (IVA) is expected to have a pivotal Phase 3 readout in 4Q for MASH F2/3, which Barclays views as likely successful.
Table of Contents
- Summary of Changes
- Company Research
- Publications Summary
- Consumer
- U.S. CHPC & Beverages
- Healthcare
- Technology
- Analyst(s) Certification(s)
- Important Disclosures
Access the Full Report
Get unlimited access to institutional research reports with a 14-day free trial.
Authors
Lauren R. LiebermanBrandt MontourLukas ShumwayEtzer DaroutEliana MerleRaimo Lenschow
Securities
DRTSODDVACIVAKURACXM
Themes
Small Cap Biotechnology CatalystsDirect-to-Consumer Advertising Risks
Regions
North AmericaUnited States